I-Londamocitinib; I-JAK1-IN-7; I-AZD4604; I-JAC34RRR7S
Iinkcukacha zeMveliso
Iithegi zeMveliso
Ubungakanani bePakethe | Ubukho | Ixabiso (USD) |
Igama leMchiza:
(2R)-N-(3-{5-fluoro-2-[2-fluoro-3-(methanesulfonyl)anilino]pyrimidin-4-yl}-1H-indol-7-yl)-3-methoxy-2- (4-methylpiperazin-1-yl) propanamide
Ikhowudi yoncumo:
O=C(NC1=CC=CC2=C1NC=C2C3=NC(NC4=CC=CC(S(=O)(C)=O)=C4F)=NC=C3F)[C@H](N5CCN(C) )CC5)COC
Ikhowudi ye-InChi:
InChI=1S/C28H31F2N7O4S/c1-36-10-12-37(13-11-36)22(16-41-2)27(38)33-21-8-4-6-17-18(14- 31-26(17)21)25-19(29)15-32 -28(35-25)34-20-7-5-9-23(24(20)30)42(3,39)40/h4-9,14-15,22,31H,10-13,16H2 ,1-3H3,(H,33,38)(H,32,34,35)/t22-/m1/s1
Isitshixo se-InChi:
JNUZADQZHYFJGW-JOCHJYFZSA-N
Igama elingundoqo:
2241039-81-4;CAS:2241039-81-4;CAS:2241039-81-4;Londamocitinib;JAK1-IN-7;AZD4604;AZD-4604;JAC34RRR7S;
Ukunyibilika:
Ugcino:Yomile, emnyama kunye ne-0 - 4 C kwixesha elifutshane (iintsuku ukuya kwiiveki) okanye -20 C ixesha elide (iinyanga ukuya kwiminyaka).
Inkcazo:
I-Londamocitinib (AZD4604) yi-JAK1 inhibitor esebenzayo ekhethiweyo.
Ithagethi: JAK1